$ATEX

Anterix (ATEX) legal chief sells shares without 10b5-1 plan

Anterix's CLO, Gena L. Ashe, exercised options for 6,833 shares at $34.96 each on September 8, 2026. 2,769 shares were withheld for taxes, and 4,357 shares were sold at $85.44 each, totaling $372K in proceeds. No 10b5-1 plan was used.

Original reporting
Published Sep 11, 2026, 8:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 10:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ATEX
Neutral
medium confidence
Mentioned
$ATEX
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ATEXNeutralLow
01

Why it matters

Provides fresh insider transaction data; limited scale suggests low trading relevance.

02

Market read

Primary disclosure of a small insider sale; unlikely to move the stock significantly.

03

What to watch

Potential tax withholding mechanics may affect net ownership but not market perception.

Relevance 4/10Novelty 4/10Timing: post‑market Sep 8 2026

Background

Form 4 filing by Anterix's chief legal officer detailing option exercise and share sale.

Company-level read

Ticker impact

$ATEXNeutralMedium confidence
Context

Chief Legal Officer Gena L. Ashe exercised 6,833 stock options and sold 4,357 shares on Sep 8, 2026, disclosed via Form 4.

Expected impact

Minor downward pressure, potential short-term dip of 1‑2% if market reacts.

Evidence & confidence

Sale size (~$372k) is modest relative to market cap; insider is not a major shareholder, and no 10b5‑1 plan was used.

Market effects

Minimal effect on telecom infrastructure sector.

Negligible impact on US markets.

None

Counterpoint

Insider sale could be a red flag if combined with other negative signals.

Key entities

  • Anterix Inc.

    US‑listed telecom infrastructure provider (ticker ATEX).

  • Gena L. Ashe

    Chief Legal Officer & Corporate Secretary of Anterix.

Related articles

$ATEXMed

Is Anterix (ATEX) Quietly Reframing Its Connectivity Moat With New 900 MHz FCC Flexibility?

Anterix (ATEX) gained attention after the FCC approved expanded 900 MHz broadband use and granted it a license for satellite testing. This could broaden its network applications and reinforce its investment narrative, though profitability currently relies heavily on noncash spectrum gains. Analysts project $6.9M revenue and $935K earnings by 2028, with a potential 36% downside from current prices.

$ATEXMed

Anterix (ATEX) Q1 2027 Earnings Call Transcript

Anterix (ATEX) reported Q1 2027 revenue of $2M, up from $1.4M YoY, with net income of $240K. Operating expenses decreased to $12.9M. The company has $116M in cash, no debt, and $226.7M left for share repurchases. Management highlighted 12 active deals, spectrum clearing progress, and support for SpaceX's FCC proposal. CFO warned of potential higher costs if spectrum clearing is accelerated.

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Anterix Inc. Reports First Quarter Fiscal Year 2027 Results Woodland Park, NJ – August 11, 2026 – Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2027 results and filed its Form 10-Q for the three months ended June 30, 2026. Financial and Operational Highlights –

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atex-20260331xpressrelease.htm EX-99.1 Document Anterix Inc. Reports Full Fiscal Year 2026 Results Woodland Park, NJ – June 10, 2026 – Anterix (NASDAQ: ATEX) today announced fiscal 2026 fourth quarter and full fiscal year financial results for the year ended March 31, 2